scholarly article | Q13442814 |
P2860 | cites work | Sunlight and age-related macular degeneration. The Beaver Dam Eye Study | Q70655027 |
Lens Opacities and Senile Maculopathy | Q70786046 | ||
Risk factors of age-related maculopathy in a population 70 years of age or older | Q71108625 | ||
A prospective study of cigarette smoking and age-related macular degeneration in women | Q71582100 | ||
Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study | Q71933360 | ||
The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study | Q73043468 | ||
Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group | Q73440318 | ||
Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III | Q77872867 | ||
Senile macular changes in the black African | Q33650851 | ||
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group | Q34323879 | ||
The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. | Q34655539 | ||
Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey | Q36455838 | ||
Ocular exposure to UV-B in sunlight: the Melbourne visual impairment project model | Q36795135 | ||
Preventative ophthalmology. Age-related macular degeneration | Q36853154 | ||
The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study | Q39820430 | ||
Antioxidants and age-related eye disease. Current and future perspectives | Q40960608 | ||
Epidemiology of age-related maculopathy. | Q41001245 | ||
The Wisconsin age-related maculopathy grading system | Q41902806 | ||
Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey | Q43587787 | ||
Exposure to sunlight and other risk factors for age-related macular degeneration | Q43660920 | ||
Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study | Q44040811 | ||
The relationship of ocular factors to the incidence and progression of age-related maculopathy | Q44412742 | ||
The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking | Q44551202 | ||
Smoking and age-related maculopathy. The Blue Mountains Eye Study | Q44591252 | ||
The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. | Q44975780 | ||
Features of age-related macular degeneration in a black population. The Barbados Eye Study Group | Q46246780 | ||
Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group | Q46603963 | ||
Cataract and age-related maculopathy: the Blue Mountains Eye Study. | Q50516063 | ||
Refractive error and age-related maculopathy: the Blue Mountains Eye Study. | Q50522416 | ||
Sample sizes for prevention trials have been too small. | Q50698054 | ||
The long-term effects of visible light on the eye. | Q50796491 | ||
Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age. | Q50869184 | ||
Senile macular degeneration: a case-control study. | Q50927753 | ||
Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. | Q50992620 | ||
Are antioxidants or supplements protective for age-related macular degeneration? | Q51596706 | ||
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group | Q56534843 | ||
Senile disciform macular degeneration and smoking | Q67325346 | ||
Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group | Q67803483 | ||
The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels | Q68090477 | ||
Prevalence of age-related maculopathy. The Beaver Dam Eye Study | Q68207448 | ||
Assessment of cataracts from photographs in the Beaver Dam Eye Study | Q68627070 | ||
Senile cataract and senile macular degeneration: an investigation into possible risk factors | Q68810230 | ||
Risk factors in age-related maculopathy complicated by choroidal neovascularization | Q68966862 | ||
Age-related macular degeneration | Q69037879 | ||
The association of age-related macular degeneration and lens opacities in the aged | Q69624187 | ||
Systemic hypertension and age-related maculopathy in the Framingham Study | Q70011828 | ||
Senile macular degeneration: a preliminary study | Q70470159 | ||
Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects | Q70574111 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | 2224-32 | |
P577 | publication date | 2000-12-01 | |
P1433 | published in | Ophthalmology | Q7098109 |
P1476 | title | Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3 | |
P478 | volume | 107 |
Q33740158 | A Review of Current and Future Management of Geographic Atrophy |
Q92301614 | A Review of Pathogenic Drivers of Age-Related Macular Degeneration, Beyond Complement, with a Focus on Potential Endpoints for Testing Therapeutic Interventions in Preclinical Studies |
Q56243468 | A comparison of risk factors for age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese patients |
Q34639285 | A genome-wide association study for primary open angle glaucoma and macular degeneration reveals novel Loci |
Q24806062 | A randomised controlled trial investigating the effect of nutritional supplementation on visual function in normal, and age-related macular disease affected eyes: design and methodology [ISRCTN78467674] |
Q24544001 | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 |
Q39618688 | A suggested association between hypothyroidism and age-related macular degeneration |
Q92523288 | A systematic approach to evaluate practice-based process- and outcome data applied to the treatment of neovascular age-related macular degeneration |
Q26744106 | AMD and the alternative complement pathway: genetics and functional implications |
Q43292216 | ARMS2/HTRA1 and CFH polymorphisms are not associated with choroidal neovascularization in highly myopic eyes of the elderly Japanese population |
Q42492505 | Absence of collagen XVIII in mice causes age-related insufficiency in retinal pigment epithelium proteostasis |
Q34551595 | Accelerated 20-year sunlight exposure simulation of a photochromic foldable intraocular lens in a rabbit model |
Q45017248 | Accumulation of lipid particles in Bruch's membrane of LDL receptor knockout mice as a model of age-related macular degeneration |
Q35983639 | Activation of the ERK 1/2 and STAT3 signaling pathways is required for 661W cell survival following oxidant injury |
Q35126587 | Activation of the UPR protects against cigarette smoke-induced RPE apoptosis through up-regulation of Nrf2. |
Q57480658 | Activator protein-1 contributes to the NaCl-induced expression of VEGF and PlGF in RPE cells |
Q47427948 | Advances in Age-related Macular Degeneration Understanding and Therapy |
Q42565175 | Advances in technology helps in early detection of vision disorders |
Q24679626 | Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight |
Q91840317 | Age-Related Macular Degeneration in Primary Osteoarthritis Egyptian Patients |
Q26799617 | Age-Related Macular Degeneration: Advances in Management and Diagnosis |
Q35126780 | Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies |
Q81372969 | Age-related macular degeneration |
Q82698020 | Age-related macular degeneration |
Q34389315 | Age-related macular degeneration and risk of stroke |
Q43252791 | Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes |
Q31048292 | Age-related macular degeneration: epidemiology and optimal treatment |
Q28506396 | Age-related retinal degeneration (arrd2) in a novel mouse model due to a nonsense mutation in the Mdm1 gene |
Q37315838 | Aging is not a disease: distinguishing age-related macular degeneration from aging |
Q51916228 | An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment. |
Q35855800 | An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation. |
Q36056865 | An association between environmental factors and the IVS4+44C>A polymorphism of the DMT1 gene in age-related macular degeneration |
Q36747203 | An update on the genetics of age-related macular degeneration. |
Q35690507 | Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular Degeneration |
Q24544270 | Analysis of Hemicentin-1, hOgg1, and E-selectin single nucleotide polymorphisms in age-related macular degeneration |
Q51759447 | Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD). |
Q34251889 | Angiotensin II-related hypertension and eye diseases |
Q34295974 | Antiangiogenic therapy for ischemic retinopathies |
Q24245483 | Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration |
Q35749021 | Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy |
Q40019102 | Asian age-related macular degeneration phenotyping study: rationale, design and protocol of a prospective cohort study |
Q37612368 | Aspirin and age related macular degeneration; the possible relationship |
Q34630065 | Aspirin use and risk of age-related macular degeneration: a meta-analysis |
Q35762418 | Associated factors for age related maculopathy in the adult population in China: the Beijing eye study |
Q33604743 | Association between Asymptomatic Unilateral Internal Carotid Artery Stenosis and Electrophysiological Function of the Retina and Optic Nerve. |
Q39963674 | Association between asymmetry in cataract and asymmetry in age-related macular degeneration. The Beijing Eye Study |
Q35737410 | Association between various types of obesity and macular pigment optical density. |
Q92524759 | Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39 |
Q64111269 | Association of HTRA1 and ARMS2 gene polymorphisms with response to intravitreal ranibizumab among neovascular age-related macular degenerative subjects |
Q43268210 | Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese women |
Q35429130 | Association of OCT derived drusen measurements with AMD associated-genotypic SNPs in Amish population |
Q57141419 | Association of obesity and age-related macular degeneration in Indian population |
Q33584512 | Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation |
Q57539245 | Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population |
Q34366242 | Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration |
Q46831464 | Australian prospective study of cataract surgery and age-related macular degeneration: rationale and methodology |
Q61804560 | Axial length and its associations in a Russian population: The Ural Eye and Medical Study |
Q42359940 | Axial length and subfoveal choroidal thickness in individuals with age-related macular degeneration |
Q39014462 | Benefits, Potential Harms, and Optimal Use of Nutritional Supplementation for Preventing Progression of Age-Related Macular Degeneration |
Q45935732 | Brimonidine Can Prevent In Vitro Hydroquinone Damage on Retinal Pigment Epithelium Cells and Retinal Müller Cells. |
Q37996128 | CFB/C2 gene polymorphisms and risk of age-related macular degeneration: a systematic review and meta-analysis. |
Q35140894 | CFH, VEGF, and PEDF genotypes and the response to intravitreous injection of bevacizumab for the treatment of age-related macular degeneration |
Q33616519 | Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study |
Q36516001 | Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study |
Q38716245 | Care of Older Adults: Role of Primary Care Physicians in the Treatment of Cataracts and Macular Degeneration. |
Q38767261 | Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases |
Q49222689 | Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. |
Q58737788 | Choriocapillaris changes in dry age-related macular degeneration and geographic atrophy: a review |
Q35005946 | Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration |
Q34930298 | Clinical characteristics and current treatment of age-related macular degeneration |
Q36274578 | Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration |
Q34437319 | Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis |
Q41494023 | Comparison of clinical features and 3-month treatment response among three different choroidal thickness groups in polypoidal choroidal vasculopathy |
Q39719940 | Comparison of stereoscopic digital imaging and slide film photography in the identification of macular degeneration. |
Q98613384 | Comparison of the Morphology of the Foveal Pit Between African and Caucasian Populations |
Q35133725 | Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium |
Q54392848 | Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration. |
Q24553334 | Complement factor H polymorphism in age-related macular degeneration |
Q37626363 | Complement-associated deposits in the human retina |
Q92132455 | Comprehensive expression patterns of inflammatory cytokines in aqueous humor of patients with neovascular age-related macular degeneration |
Q54317190 | Contribution of the Nurses' Health Study to the Epidemiology of Cataract, Age-Related Macular Degeneration, and Glaucoma. |
Q33507197 | Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach |
Q28732075 | Copy number variation of age-related macular degeneration relevant genes in the Korean population |
Q91045147 | Correlation of axial length and myopic macular degeneration to levels of molecular factors in the aqueous |
Q37879172 | Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures |
Q36841141 | Current smoking is associated with a poor visual acuity improvement after intravitreal ranibizumab therapy in patients with exudative age-related macular degeneration |
Q36218094 | DETECTION OF NONEXUDATIVE CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. |
Q36364712 | Daytime presentations to a metropolitan ophthalmic emergency department. |
Q35908535 | Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration |
Q37566563 | Dietary and lifestyle risk factors associated with age-related macular degeneration: a hospital based study |
Q80941948 | Differences in reading performance of patients with Drusen maculopathy and subretinal fibrosis after CNV |
Q38189104 | Does long-term aspirin use increase the risk of neovascular age-related macular degeneration? |
Q36313773 | Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years. |
Q34378033 | Dry age-related macular degeneration: A currently unmet clinical need |
Q35857083 | Effect of High-Density Lipoprotein Metabolic Pathway Gene Variations and Risk Factors on Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in China |
Q35918965 | Effect of aspirin on models of retinal pigment epithelium pathology |
Q33234332 | Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration |
Q91584129 | Effects of Lutein Supplementation in Japanese Patients with Unilateral Age-Related Macular Degeneration: The Sakai Lutein Study |
Q33773175 | Effects of bevacizumab on endoplasmic reticulum stress in hypoxic retinal pigment epithelial cells |
Q46259787 | Effects of ginkgo biloba extract on cultured human retinal pigment epithelial cells under chemical hypoxia |
Q60054053 | Effects of senescent secretory phenotype acquisition on human retinal pigment epithelial stem cells |
Q40615188 | Epidemiology of age-related macular degeneration |
Q30239897 | Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors |
Q35560422 | Epidemiology of age-related maculopathy: a review |
Q36124940 | Erp29 Attenuates Cigarette Smoke Extract-Induced Endoplasmic Reticulum Stress and Mitigates Tight Junction Damage in Retinal Pigment Epithelial Cells |
Q37065197 | Estimated prevalence and risk factor for age-related maculopathy |
Q90291055 | Evaluation of Peripheral Retinal Changes on Ultra-Widefield Fundus Autofluorescence Images of Patients with Age-Related Macular Degeneration |
Q58602996 | Evaluation of the Relationship Between Age-related Macular Degeneration and Refractive Error, Socio-demographic Features, and Biochemical Variables in a Turkish Population |
Q55190215 | Evidence for an Association between Macular Degeneration and Thyroid Cancer in the Aged Population. |
Q43083299 | Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice |
Q37187115 | Eye Care Disparities and Health-Related Consequences in Elderly Patients with Age-Related Eye Disease |
Q36205759 | Features of Age-Related Macular Degeneration in the General Adults and Their Dependency on Age, Sex, and Smoking: Results from the German KORA Study |
Q56555464 | Fluorescein Angiography Does Not Alter the Initial Clinical Management of Choroidal Neovascularization in Age-Related Macular Degeneration |
Q89440936 | Food groups and risk of age-related macular degeneration: a systematic review with meta-analysis |
Q97692887 | Functional imaging of mitochondria in retinal diseases using flavoprotein fluorescence |
Q36467703 | Functional single nucleotide polymorphism in IL-17A 3' untranslated region is targeted by miR-4480 in vitro and may be associated with age-related macular degeneration |
Q48346190 | Gender Differences in the Relationship between Sex Hormone Deficiency and Soft Drusen |
Q47105600 | Genetic association study of age-related macular degeneration in the Spanish population |
Q28396822 | Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study |
Q37901276 | Genetic factors associated with age-related macular degeneration |
Q28943491 | Genetic factors in nonsmokers with age-related macular degeneration revealed through genome-wide gene-environment interaction analysis |
Q35749765 | Genetic factors of age-related macular degeneration |
Q36732124 | Genome-wide analysis of copy number variants in age-related macular degeneration |
Q36031664 | Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration |
Q92886662 | Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Late-stage Age-Related Macular Degeneration |
Q54990705 | Gonadal Hormones and Retinal Disorders: A Review. |
Q57176321 | Gout and the risk of age-related macular degeneration in the elderly |
Q33307521 | Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration |
Q38807163 | Heritability of Choroidal Thickness in the Amish. |
Q35761771 | High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture |
Q98563377 | Home Monitoring of Age-Related Macular Degeneration: Real-World Utility of the ForeseeHome Device for Detection of Neovascularization |
Q90598579 | Hypertension, antihypertensive medications use and risk of age-related macular degeneration in California Teachers Cohort |
Q37265929 | Identification of a rare coding variant in complement 3 associated with age-related macular degeneration |
Q33935415 | Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics. |
Q64065229 | Impact of systemic vascular risk factors on the choriocapillaris using optical coherence tomography angiography in patients with systemic hypertension |
Q44924511 | Impact of visual impairment on service and device use by individuals with age-related macular degeneration (AMD). |
Q33848714 | In-depth analyses unveil the association and possible functional involvement of novel RAD51B polymorphisms in age-related macular degeneration |
Q34114772 | Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis |
Q37186026 | Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration |
Q92609620 | Inhibition of thyroid hormone signaling protects retinal pigment epithelium and photoreceptors from cell death in a mouse model of age-related macular degeneration |
Q37526810 | Intake of dietary salt and drinking water: Implications for the development of age-related macular degeneration |
Q24246549 | Interferon alfa therapy for age-related macular degeneration |
Q35095517 | Intracameral interleukin 1β, 6, 8, 10, 12p, tumor necrosis factor α and vascular endothelial growth factor and axial length in patients with cataract |
Q48216065 | Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor |
Q36925652 | Intravitreal ranibizumab and bevacizumab: a review of risk |
Q33844950 | Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms |
Q52359171 | Investigating the modulation of genetic effects on late AMD by age and sex: Lessons learned and two additional loci. |
Q37206264 | Is age-related macular degeneration associated with stroke among elderly americans? |
Q55003687 | KUS121, an ATP regulator, mitigates chorioretinal pathologies in animal models of age-related macular degeneration. |
Q32125469 | LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis |
Q35000314 | Light filtering in a retinal pigment epithelial cell culture model |
Q37011339 | Lipid metabolites in the pathogenesis and treatment of neovascular eye disease |
Q58715760 | Low incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) in high-risk AMD |
Q43833541 | Lutein and zeaxanthin for macular degeneration |
Q41111119 | Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model. |
Q45233235 | MEF2D haploinsufficiency downregulates the NRF2 pathway and renders photoreceptors susceptible to light-induced oxidative stress. |
Q43007001 | Macular degeneration associated with a novel Treacher Collins tcof1 mutation and evaluation of this mutation in age related macular degeneration. |
Q104064473 | Macular retinal thickness differs markedly in age-related macular degeneration driven by risk polymorphisms on chromosomes 1 and 10 |
Q37349992 | Macular zeaxanthins and lutein -- a review of dietary sources and bioavailability and some relationships with macular pigment optical density and age-related macular disease |
Q48622797 | Magnification-corrected photodynamic therapy. |
Q91660747 | Microvascular contributions to age-related macular degeneration (AMD): from mechanisms of choriocapillaris aging to novel interventions |
Q28255630 | Mitochondrial variation and the risk of age-related macular degeneration across diverse populations |
Q33227050 | Modelling the natural history of geographic atrophy in patients with age-related macular degeneration |
Q34509841 | Monitoring of drusen and geographic atrophy area size after cataract surgery using the MD3RI tool for computer-aided contour drawing. |
Q33388699 | Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration |
Q38492049 | Münster age- and retina study (MARS). Association between risk factors for arteriosclerosis and age-related macular degeneration |
Q26799766 | NLRP3 Inflammasome and Pathobiology in AMD |
Q38174408 | Nature and nurture- genes and environment- predict onset and progression of macular degeneration. |
Q34634743 | Neuroprotective effects of lutein in the retina |
Q40649624 | No Sex Differences in the Frequencies of Common Single Nucleotide Polymorphisms Associated with Age-Related Macular Degeneration |
Q40028590 | OT-674 suppresses photooxidative processes initiated by an RPE lipofuscin fluorophore. |
Q36758799 | Obesity and eye diseases |
Q39833372 | Ocular and systemic factors associated with diabetes mellitus in the adult population in rural and urban China. The Beijing Eye Study |
Q35968037 | Ocular associations of metabolic syndrome |
Q39349855 | Optical Coherence Tomographic Angiography Imaging in Age-Related Macular Degeneration |
Q26748464 | Optical Coherence Tomography Angiography in Retinal Diseases |
Q24793439 | Ordered subset linkage analysis supports a susceptibility locus for age-related macular degeneration on chromosome 16p12 |
Q41188051 | Overexpressed or intraperitoneally injected human transferrin prevents photoreceptor degeneration in rd10 mice |
Q44584637 | Oxidative stress and anti-oxidative defence in patients with age-related macular degeneration |
Q46824949 | Oxidative stress in dry age-related macular degeneration and exfoliation syndrome |
Q92572396 | Periodontal Diseases and Age-Related Macular Degeneration: Is There a Link? A Review |
Q36424457 | Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population |
Q46415528 | Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration |
Q37897749 | Polarization sensitive optical coherence tomography in the human eye. |
Q95327166 | Predicting conversion to wet age-related macular degeneration using deep learning |
Q92059732 | Predictors of neovascular activity during neovascular age-related macular degeneration treatment based on optical coherence tomography angiography |
Q33759162 | Prevalence and risk factors for age-related macular degeneration in the elderly Chinese population in south-western Taiwan: the Puzih eye study |
Q40186146 | Prevalence and risk factors for age-related macular degeneration: Korean National Health and Nutrition Examination Survey 2008-2011. |
Q38775043 | Prevalence of Age-Related Macular Degeneration in Slovakia and Associated Risk Factors: A Mobile Clinic-Based Cross-Sectional Epidemiological Survey |
Q36294040 | Prevalence of age-related macular degeneration among the elderly |
Q33739809 | Prevalence of and risk factors for age-related macular degeneration in Nepal: the Bhaktapur Retina Study |
Q34728024 | Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration |
Q34491498 | Prevention of age-related macular degeneration |
Q36894556 | Progress in defining the molecular biology of age related macular degeneration |
Q37407570 | Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus |
Q33996503 | Progression of geographic atrophy and genotype in age-related macular degeneration |
Q30543909 | Quantitative fundus autofluorescence in healthy eyes. |
Q34001750 | R102G polymorphism of the C3 gene associated with exudative age-related macular degeneration in a French population |
Q34646882 | Race- and sex-related differences in retinal thickness and foveal pit morphology. |
Q34449898 | Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration. |
Q36377333 | Recent advances in the management of dry age-related macular degeneration: A review |
Q41532061 | Recent developments in age-related macular degeneration: a review. |
Q35112876 | Refractive error and risk of early or late age-related macular degeneration: a systematic review and meta-analysis |
Q44294059 | Refractive error and smoking habits in exudative age-related macular degeneration in a hospital-based setting |
Q39909122 | Refractive error, ocular and general parameters and ophthalmic diseases. The Beijing Eye Study |
Q35740328 | Regulation of age-related macular degeneration-like pathology by complement factor H. |
Q99562754 | Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Correlation with Macular Function |
Q54714141 | Retinal blood flow velocity in patients with age-related macular degeneration. |
Q42963793 | Retinal degeneration increases susceptibility to myopia in mice |
Q38725575 | Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration. |
Q37039797 | Review of genetics in age related macular degeneration. |
Q38174238 | Review of the role of refined dietary sugars (fructose and glucose) in the genesis of retinal disease |
Q38828895 | Risk factors and biomarkers of age-related macular degeneration |
Q34084938 | Risk factors associated with age-related nuclear and cortical cataract : a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5. |
Q35590853 | Risk factors for age related maculopathy in a Japanese population: the Hisayama study |
Q33720834 | Risk factors for age-related maculopathy |
Q39624600 | Risk factors for exudative age-related macular degeneration in a large French case-control study |
Q89888023 | Risk factors for progression of age-related macular degeneration |
Q24554181 | Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19 |
Q34491990 | Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. |
Q37111954 | Role of ocular melanin in ophthalmic physiology and pathology |
Q37612307 | Role of statins in the development and progression of age-related macular degeneration. |
Q89702866 | Sensitivity and Specificity of OCT Angiography to Detect Choroidal Neovascularization |
Q35761464 | Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation |
Q34449581 | Smoking and age-related macular degeneration: a review of association. |
Q34394380 | Smoking and age-related macular degeneration: review and update |
Q42000152 | Smoking and choroidal thickness in patients over 65 with early-atrophic age-related macular degeneration and normals |
Q35230959 | Smoking, antioxidant supplementation and dietary intakes among older adults with age-related macular degeneration over 10 years |
Q37013472 | Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications |
Q44158875 | Statin use and the risk of age related macular degeneration in a large health organization in Israel |
Q34021032 | Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration |
Q36350410 | Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration. |
Q24202631 | Surgery for cataracts in people with age-related macular degeneration |
Q24241331 | Surgery for cataracts in people with age-related macular degeneration |
Q30235923 | Surgery for cataracts in people with age-related macular degeneration. |
Q38043013 | Susceptibility genes and pharmacogenetics in ocular inflammatory disorders |
Q36350405 | Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population. |
Q34657946 | Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition |
Q38914781 | Systematic Functional Testing of Rare Variants: Contributions of CFI to Age-Related Macular Degeneration |
Q37365352 | Systems Biology Profiling of AMD on the Basis of Gene Expression |
Q36023209 | Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks |
Q34653094 | The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17 |
Q36315753 | The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9 |
Q37030323 | The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples |
Q24678569 | The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples |
Q37406856 | The Royal College of Ophthalmologists Guidelines on AMD: Executive Summary |
Q37457180 | The Royal College of Ophthalmologists' National Ophthalmology Database Study of cataract surgery: report 2, relationships of axial length with ocular copathology, preoperative visual acuity, and posterior capsule rupture |
Q60907321 | The association between socioeconomic status and visual disability among older adults in China |
Q44399930 | The association of cardiovascular disease with the long-term incidence of age-related maculopathy |
Q45905000 | The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. |
Q38077553 | The immunological basis of degenerative diseases of the eye. |
Q37678798 | The molecular genetic basis of age-related macular degeneration: an overview |
Q39024579 | The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target |
Q35593582 | The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study |
Q74138286 | The relation of socioeconomic factors to the incidence of early age-related maculopathy: the Beaver Dam eye study |
Q44548607 | The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study |
Q33914613 | The relationship of major American dietary patterns to age-related macular degeneration |
Q47112476 | The retina/RPE proteome in chick myopia and hyperopia models: Commonalities with inherited and age-related ocular pathologies |
Q92360633 | The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective |
Q36405906 | The role of inflammation in the pathogenesis of age-related macular degeneration |
Q24802193 | The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence |
Q42132169 | The vitreomacular interface in different types of age-related macular degeneration. |
Q35530361 | Thyroid function and age-related macular degeneration: a prospective population-based cohort study--the Rotterdam Study |
Q35530507 | Thyroid function: a new road to understanding age-related macular degeneration? |
Q33950814 | Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples |
Q57838890 | Transplantation in the treatment of age-related macular degeneration: past, present and future directions |
Q36697237 | Unfolding the Therapeutic Potential of Chemical Chaperones for Age-related Macular Degeneration |
Q36311846 | Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration |
Q37045695 | Use of lipid-lowering agents for the prevention of age-related macular degeneration: a meta-analysis of observational studies |
Q37545004 | VEGF regulates local inhibitory complement proteins in the eye and kidney. |
Q37834016 | Vascular endothelial growth factors in retinal and choroidal neovascular diseases |
Q37590193 | Visual impairment and blindness: an overview of prevalence and causes in Brazil |
Q37715254 | Visualization of Dietary Patterns and Their Associations With Age-Related Macular Degeneration |
Q34786173 | Vitamin D status and early age-related macular degeneration in postmenopausal women |
Q37222581 | Whole exome sequencing of extreme age-related macular degeneration phenotypes |
Q36171917 | Wnt signaling in age-related macular degeneration: human macular tissue and mouse model |
Q39039293 | Y402H polymorphism in complement factor H and age-related macular degeneration in the Tunisian population |
Q33508828 | rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration |
Q37421203 | {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study |
Search more.